{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T05:56:56Z","timestamp":1794376616176,"version":"4.9.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007268","name":"Washington University in St. Louis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005301","name":"American College of Surgeons","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005301","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jtct.2026.01.019","type":"journal-article","created":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T23:47:17Z","timestamp":1768520837000},"page":"723-734","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Disparities in Allogeneic Hematopoietic Stem Cell Transplantation Among Acute Myeloid Leukemia Patients"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-7367-7485","authenticated-orcid":false,"given":"Lixin Cindy","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0208-5023","authenticated-orcid":false,"given":"Mark A.","family":"Fiala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8152-7319","authenticated-orcid":false,"given":"Kimberly J.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2026.01.019_bib0002","unstructured":"Key Statistics for Acute Myeloid Leukemia (AML). Accessed March 29, 2025. Available at: https:\/\/www.cancer.org\/cancer\/types\/acute-myeloid-leukemia\/about\/key-statistics.html"},{"issue":"22","key":"10.1016\/j.jtct.2026.01.019_bib0003","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1001\/jama.2009.813","article-title":"Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials","volume":"301","author":"Koreth","year":"2009","journal-title":"JAMA"},{"issue":"30","key":"10.1016\/j.jtct.2026.01.019_bib0004","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1200\/JCO.2010.28.6856","article-title":"Prospective evaluation of allogeneic hematopoietic stem-cell transplantation from matched related and matched unrelated donors in younger adults with high-risk acute myeloid leukemia: German-Austrian trial AMLHD98A","volume":"28","author":"Schlenk","year":"2010","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"4","key":"10.1016\/j.jtct.2026.01.019_bib0005","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1200\/JCO.2013.50.5768","article-title":"Allogeneic transplantation versus chemotherapy as postremission therapy for acute myeloid leukemia: a prospective matched pairs analysis","volume":"32","author":"Stelljes","year":"2014","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.jtct.2026.01.019_bib0006","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jtct.2025.05.014","article-title":"Current activity trends and outcomes in hematopoietic cell transplantation and cellular therapy \u2013 a report from the CIBMTR","volume":"31","author":"Spellman","year":"2025","journal-title":"Transplant Cell Ther"},{"issue":"7","key":"10.1016\/j.jtct.2026.01.019_bib0007","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/s41409-018-0105-9","article-title":"Use of hematopoietic cell transplantation in younger patients with acute myeloid leukemia: a national cancer database study","volume":"53","author":"Bhatt","year":"2018","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.jtct.2026.01.019_bib0008","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174760","article-title":"Sociodemographic disparities in chemotherapy and hematopoietic cell transplantation utilization among adult acute lymphoblastic and acute myeloid leukemia patients","volume":"12","author":"Jabo","year":"2017","journal-title":"PLOS ONE"},{"issue":"8","key":"10.1016\/j.jtct.2026.01.019_bib0009","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.bbmt.2009.12.529","article-title":"Access to hematopoietic cell transplantation in the United States","volume":"16","author":"Majhail","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"10.1016\/j.jtct.2026.01.019_bib0010","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1016\/j.bbmt.2019.06.012","article-title":"Inferior access to allogeneic transplant in disadvantaged populations: a center for international blood and marrow transplant research analysis","volume":"25","author":"Paulson","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"12","key":"10.1016\/j.jtct.2026.01.019_bib0011","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1200\/JCO.19.02232","article-title":"Allogeneic hematopoietic cell transplantation and other expensive cellular therapies: a miracle for the few but off limits to many?","volume":"38","author":"Khera","year":"2020","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"12","key":"10.1016\/j.jtct.2026.01.019_bib0012","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/j.bbmt.2020.09.013","article-title":"Barriers to hematopoietic cell transplantation for adults in the united states: a systematic review with a focus on age","volume":"26","author":"Flannelly","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jtct.2026.01.019_bib0013","doi-asserted-by":"crossref","first-page":"184.e1","DOI":"10.1016\/j.bbmt.2020.10.004","article-title":"Likelihood of proceeding to allogeneic hematopoietic cell transplantation in the United States after search activation in the national registry: impact of patient age, disease, and search prognosis","volume":"27","author":"Dehn","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2026.01.019_bib0014","doi-asserted-by":"crossref","unstructured":"Gragert L, Eapen M, Williams E, et al. HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. Registry. New Engl J Med.doi:10.1056\/NEJMsa1311707","DOI":"10.1056\/NEJMsa1311707"},{"issue":"7","key":"10.1016\/j.jtct.2026.01.019_bib0015","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1182\/bloodadvances.2018028662","article-title":"Racial disparities in access to HLA-matched unrelated donor transplants: a prospective 1312-patient analysis","volume":"3","author":"Barker","year":"2019","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.jtct.2026.01.019_bib0016","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/hematology.2021000259","article-title":"Increasing access to allotransplants in the United States: the impact of race, geography, and socioeconomics","volume":"2021","author":"Hong","year":"2021","journal-title":"Hematology"},{"issue":"Supplement 1","key":"10.1016\/j.jtct.2026.01.019_bib0017","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1182\/blood-2023-179249","article-title":"Factors associated with treatment receipt in medicare beneficiaries diagnosed with acute myeloid leukemia","volume":"142","author":"Preussler","year":"2023","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.jtct.2026.01.019_bib0019","doi-asserted-by":"crossref","first-page":"346.e1","DOI":"10.1016\/j.jtct.2023.03.007","article-title":"Real-world data showing trends and outcomes by race and ethnicity in allogeneic hematopoietic cell transplantation: a report from the Center for International Blood and Marrow Transplant Research","volume":"29","author":"Auletta","year":"2023","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2026.01.019_bib0020","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.614215","article-title":"Role of hematopoietic stem cell transplantation in acute promyelocytic leukemia","volume":"11","author":"Sanz","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.jtct.2026.01.019_bib0021","unstructured":"First Course Treatment | SEER Training. Accessed December 7, 2025. Available at: https:\/\/training.seer.cancer.gov\/treatment\/first-course\/"},{"key":"10.1016\/j.jtct.2026.01.019_bib0022","unstructured":"Participant User Files. ACS. Accessed March 2, 2025. Available at: https:\/\/www.facs.org\/quality-programs\/cancer-programs\/national-cancer-database\/puf\/"},{"issue":"4","key":"10.1016\/j.jtct.2026.01.019_bib0023","doi-asserted-by":"crossref","first-page":"S316","DOI":"10.1016\/j.healun.2020.01.713","article-title":"Charlson-Deyo-comorbidity-index predicts long-term survival in lung transplantation","volume":"39","author":"Ehrsam","year":"2020","journal-title":"J Heart Lung Transplant"},{"issue":"24","key":"10.1016\/j.jtct.2026.01.019_bib0024","doi-asserted-by":"crossref","first-page":"5770","DOI":"10.3390\/cancers15245770","article-title":"Charlson\u2013Deyo comorbidity index as a novel predictor for recurrence in non-muscle-invasive bladder cancer","volume":"15","author":"Scheipner","year":"2023","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.jtct.2026.01.019_bib0025","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"Deyo","year":"1992","journal-title":"J Clin Epidemiol"},{"issue":"15","key":"10.1016\/j.jtct.2026.01.019_bib0026","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1182\/bloodadvances.2023009765","article-title":"Improved access to HCT with reduced racial disparities through integration with leukemia care and haploidentical donors","volume":"7","author":"Bashey","year":"2023","journal-title":"Blood Adv"},{"issue":"14","key":"10.1016\/j.jtct.2026.01.019_bib0027","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1002\/cncr.25297","article-title":"Access to hematopoietic stem cell transplantation","volume":"116","author":"Joshua","year":"2010","journal-title":"Cancer"},{"issue":"25","key":"10.1016\/j.jtct.2026.01.019_bib0028","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1182\/blood.2024027543","article-title":"Social determinants of health and access to allogeneic hematopoietic cell transplantation for acute myeloid leukemia","volume":"145","author":"Wuliji","year":"2025","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.jtct.2026.01.019_bib0029","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1182\/bloodadvances.2023012469","article-title":"Trends in volumes and survival after hematopoietic cell transplantation in racial\/ethnic minorities","volume":"8","author":"Khera","year":"2024","journal-title":"Blood Adv"},{"issue":"23","key":"10.1016\/j.jtct.2026.01.019_bib0030","doi-asserted-by":"crossref","first-page":"5077","DOI":"10.1002\/cncr.33171","article-title":"Age no bar: a CIBMTR analysis of elderly patients undergoing autologous hematopoietic cell transplantation for multiple myeloma","volume":"126","author":"Munshi","year":"2020","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.jtct.2026.01.019_bib0031","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1080\/13696998.2017.1364648","article-title":"Real-world economic burden of hematopoietic cell transplantation among a large US commercially insured population with hematologic malignancies","volume":"20","author":"Bonafede","year":"2017","journal-title":"J Med Econ"},{"issue":"9","key":"10.1016\/j.jtct.2026.01.019_bib0032","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.bbmt.2014.05.011","article-title":"Financial burden in recipients of allogeneic hematopoietic cell transplantation","volume":"20","author":"Khera","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jtct.2026.01.019_bib0033","doi-asserted-by":"crossref","first-page":"489","DOI":"10.31557\/APJCP.2023.24.2.489","article-title":"The direct and indirect costs of cancer among the lower-income group: estimates from a pilot and feasibility study","volume":"24","author":"Aminuddin","year":"2023","journal-title":"Asian Pac J Cancer Prev APJCP"},{"issue":"11","key":"10.1016\/j.jtct.2026.01.019_bib0034","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1016\/j.bbmt.2018.06.015","article-title":"Quality of life of caregivers of hematopoietic cell transplant recipients","volume":"24","author":"Jamani","year":"2018","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"issue":"5","key":"10.1016\/j.jtct.2026.01.019_bib0035","first-page":"e622","article-title":"The direct and indirect financial costs of informal cancer care: a scoping review","volume":"27","author":"Coumoundouros","year":"2019","journal-title":"Health Soc Care Community"},{"issue":"7","key":"10.1016\/j.jtct.2026.01.019_bib0036","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.22214","article-title":"Acceptance of simulated adult patients with medicaid insurance seeking care in a cancer hospital for a new cancer diagnosis","volume":"5","author":"Marks","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"12","key":"10.1016\/j.jtct.2026.01.019_bib0037","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1002\/ajh.27084","article-title":"Prospective analysis to determine barriers to allogeneic hematopoietic cell transplantation in patients with acute leukemia","volume":"98","author":"Nath","year":"2023","journal-title":"Am J Hematol"},{"issue":"11","key":"10.1016\/j.jtct.2026.01.019_bib0038","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.1182\/blood-2003-09-3118","article-title":"Differences in prognostic factors and outcomes in African Americans and whites with acute myeloid leukemia","volume":"103","author":"Sekeres","year":"2004","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jtct.2026.01.019_bib0039","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1200\/JCO.2015.63.3826","article-title":"Allogeneic hematopoietic cell transplantation for acute myeloid leukemia: time to move toward a minimal residual disease\u2013based definition of complete remission?","volume":"34","author":"Araki","year":"2016","journal-title":"J Clin Oncol"},{"issue":"18","key":"10.1016\/j.jtct.2026.01.019_bib0040","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1200\/JCO.20.03502","article-title":"National marrow donor program-sponsored multicenter, Phase II trial of HLA-mismatched unrelated donor bone marrow transplantation using post-transplant cyclophosphamide","volume":"39","author":"Shaw","year":"2021","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"Supplement 1","key":"10.1016\/j.jtct.2026.01.019_bib0041","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1182\/blood-2023-172722","article-title":"Post-transplant cyclophosphamide eliminates disparity in GvHD-free, relapse-free survival and overall survival between 8\/8 Matched and 7\/8 mismatched unrelated donor hematopoietic cell transplantation in adults with hematologic malignancies","volume":"142","author":"Auletta","year":"2023","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.jtct.2026.01.019_bib0042","doi-asserted-by":"crossref","first-page":"686.e1","DOI":"10.1016\/j.jtct.2023.08.014","article-title":"Existence of HLA-mismatched unrelated donors closes the gap in donor availability Regardless of recipient ancestry","volume":"29","author":"Chowdhury","year":"2023","journal-title":"Transplant Cell Ther"},{"issue":"25","key":"10.1016\/j.jtct.2026.01.019_bib0043","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1200\/JCO-25-00856","article-title":"Post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis after mismatched unrelated donor peripheral blood stem cell transplantation","volume":"43","author":"Al Malki","year":"2025","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.jtct.2026.01.019_bib0044","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1016\/j.bbmt.2011.11.004","article-title":"Back to the future: mismatched unrelated donor, haploidentical related donor, or unrelated umbilical cord blood transplantation?","volume":"18","author":"Anasetti","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2026.01.019_bib0045","doi-asserted-by":"crossref","first-page":"S279","DOI":"10.1016\/j.bbmt.2015.11.723","article-title":"Underreporting of allotransplant data in NCDB","volume":"22","author":"Master","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jtct.2026.01.019_bib0046","first-page":"368","article-title":"Utilization of allogeneic hematopoietic stem cell transplantation among patients with newly diagnosed acute myeloid leukemia in California: a population-based linked dataset study","volume":"110","author":"Meyer","year":"2025","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.jtct.2026.01.019_bib0047","doi-asserted-by":"crossref","first-page":"859.e1","DOI":"10.1016\/j.jtct.2022.09.016","article-title":"Linking the center for international blood and marrow transplant research registry to the California Cancer Registry and California Hospital Patient Discharge Data","volume":"28","author":"Keegan","year":"2022","journal-title":"Transplant Cell Ther"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726000539?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636726000539?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T21:16:06Z","timestamp":1781212566000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636726000539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2666636726000539"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2026.01.019","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disparities in Allogeneic Hematopoietic Stem Cell Transplantation Among Acute Myeloid Leukemia Patients","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2026.01.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Society for Transplantation and Cellular Therapy.","name":"copyright","label":"Copyright"}]}}